Search Results 1-10 of 16121 for Scleroderma
Scleroderma (sklair-oh-DUR-muh), also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin.
Medicines that suppress the immune system, such as those taken after organ transplants, may help reduce progression of some scleroderma symptoms, such as the ...
Scleroderma, also called systemic sclerosis, is a complex autoimmune disease that can affect many organ systems besides the skin. ... Clinic staff will coordinate ...
Scleroderma is a disease that causes the body's connective tissue and skin to harden and tighten. In some cases, only the skin is involved. But the disease can ...
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of 12 weeks of RO7303509 treatment in patients with systemic sclerosis ( ...
This group of rare diseases involves the hardening and tightening of the skin and connective tissues. Some forms can affect internal organs.
Esophageal motor dysfunction characterized by a hypotensive lower esophageal sphincter and absent peristalsis, often called scleroderma esophagus, is a common ...
The purpose of this study is to allow standardized collection of clinical information, survey information, and blood samples from patients with scleroderma, and ...
This is a mechanistic research study to evaluate the relationship between cough, reflux, and aspiration in patients with systemic sclerosis (scleroderma).
About this study. The purpose of this study is to to develop an early systemic sclerosis ((SSc), scleroderma defined as < 5 years from 1st non- Raynaud's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.